Lisa Willits

2.8k total citations
16 papers, 2.1k citations indexed

About

Lisa Willits is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Lisa Willits has authored 16 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 11 papers in Physiology and 1 paper in Pediatrics, Perinatology and Child Health. Recurrent topics in Lisa Willits's work include Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers), Asthma and respiratory diseases (11 papers) and Respiratory Support and Mechanisms (9 papers). Lisa Willits is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers), Asthma and respiratory diseases (11 papers) and Respiratory Support and Mechanisms (9 papers). Lisa Willits collaborates with scholars based in United Kingdom, United States and Australia. Lisa Willits's co-authors include Paul Jones, Peter M.A. Calverley, Julie Yates, Bartolomé R. Celli, Gary T. Ferguson, Jørgen Vestbo, Julie A. Anderson, Christine Jenkins, Courtney Crim and P. M. A. Calverley and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, PEDIATRICS and CHEST Journal.

In The Last Decade

Lisa Willits

15 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa Willits United Kingdom 11 1.9k 1.2k 162 104 92 16 2.1k
Hana Muellerova United Kingdom 18 1.2k 0.6× 571 0.5× 153 0.9× 84 0.8× 101 1.1× 30 1.3k
Maggie Tabberer United Kingdom 19 2.0k 1.1× 1.5k 1.2× 98 0.6× 77 0.7× 85 0.9× 69 2.3k
З. Р. Айсанов Russia 15 759 0.4× 317 0.3× 131 0.8× 67 0.6× 64 0.7× 59 865
Juan Antonio Trigueros Spain 15 1.3k 0.7× 769 0.6× 117 0.7× 100 1.0× 41 0.4× 39 1.4k
Sami Saarelainen Finland 15 603 0.3× 542 0.4× 47 0.3× 25 0.2× 36 0.4× 22 971
Silvia Tognella Italy 19 684 0.4× 542 0.4× 69 0.4× 70 0.7× 39 0.4× 56 904
Luis Manuel Entrenas Costa Spain 11 401 0.2× 403 0.3× 18 0.1× 17 0.2× 6 0.1× 33 995
Mette Thomsen Denmark 8 534 0.3× 292 0.2× 113 0.7× 46 0.4× 172 1.9× 14 980
Claudio Micheletto Italy 20 816 0.4× 802 0.6× 50 0.3× 89 0.9× 21 0.2× 104 1.3k
Krishna Bajee Sriram Australia 17 485 0.3× 93 0.1× 103 0.6× 17 0.2× 104 1.1× 52 893

Countries citing papers authored by Lisa Willits

Since Specialization
Citations

This map shows the geographic impact of Lisa Willits's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Willits with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Willits more than expected).

Fields of papers citing papers by Lisa Willits

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Willits. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Willits. The network helps show where Lisa Willits may publish in the future.

Co-authorship network of co-authors of Lisa Willits

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Willits. A scholar is included among the top collaborators of Lisa Willits based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Willits. Lisa Willits is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lomas, David A., David A. Lipson, Bruce E. Miller, et al.. (2011). An Oral Inhibitor of p38 MAP Kinase Reduces Plasma Fibrinogen in Patients With Chronic Obstructive Pulmonary Disease. The Journal of Clinical Pharmacology. 52(3). 416–424. 91 indexed citations
2.
Celli, Bartolomé R., Jørgen Vestbo, Christine Jenkins, et al.. (2010). Sex Differences in Mortality and Clinical Expressions of Patients with Chronic Obstructive Pulmonary Disease: The TORCH Experience. American Journal of Respiratory and Critical Care Medicine. 183(3). 317–322. 135 indexed citations
3.
Calverley, Peter M.A., Julie A. Anderson, Bartolomé R. Celli, et al.. (2010). Cardiovascular events in patients with COPD: TORCH Study results. Thorax. 65(8). 719–725. 155 indexed citations
4.
Calverley, Peter M.A., Robert A. Stockley, Terence Seemungal, et al.. (2010). Reported Pneumonia in Patients With COPD. CHEST Journal. 139(3). 505–512. 117 indexed citations
5.
Crim, Courtney, Peter Calverley, Julie A. Anderson, et al.. (2009). Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. European Respiratory Journal. 34(3). 641–647. 319 indexed citations
6.
Ferguson, Gary T., Peter M.A. Calverley, Julie A. Anderson, et al.. (2009). Prevalence and Progression of Osteoporosis in Patients With COPD. CHEST Journal. 136(6). 1456–1465. 194 indexed citations
7.
Vestbo, Jørgen, Julie A. Anderson, Peter M.A. Calverley, et al.. (2009). Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 64(11). 939–943. 392 indexed citations
8.
Jenkins, Christine, Paul Jones, Peter M.A. Calverley, et al.. (2009). Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respiratory Research. 10(1). 59–59. 265 indexed citations
9.
Celli, Bartolomé R., Julie A. Anderson, P. M. A. Calverley, et al.. (2009). Gender Differences in Mortality of Patients with COPD: Results from the TORCH Study.. A2469–A2469. 1 indexed citations
10.
Jenkins, Christine, B.R. Celli, J. Anderson, et al.. (2009). Salmeterol/Fluticasone Propionate (SFC) Is Efficacious in GOLD Stage II COPD Patients: Analysis from the TORCH Study.. A6186–A6186. 3 indexed citations
11.
Bisgaard, Hans, et al.. (2004). Twelve-Month Safety and Efficacy of Inhaled Fluticasone Propionate in Children Aged 1 to 3 Years With Recurrent Wheezing. PEDIATRICS. 113(2). e87–e94. 112 indexed citations
12.
Jones, Paul, et al.. (2003). Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations. European Respiratory Journal. 21(1). 68–73. 180 indexed citations
13.
Calverley, Peter M.A., et al.. (2003). Withdrawal From Treatment as an Outcome in the ISOLDE Study of COPD. CHEST Journal. 124(4). 1350–1356. 83 indexed citations
14.
Calverley, Peter M.A., Sally Spencer, Lisa Willits, Sherwood Burge, & Paul Jones. (2002). Inhaled corticosteroids prevent treatment failure in COPD.. Lancaster EPrints (Lancaster University). 1 indexed citations
16.
Willits, Lisa, et al.. (2001). A Comparison of Fluticasone Propionate, 100??g Twice Daily, Administered Via a CFC and Non-CFC Propellant, HFA 134a, in Adult Patients with Asthma. Clinical Drug Investigation. 21(10). 695–703. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026